Medico Remedies Limited has submitted to the Exchange, the financial results for the period ended September 30, 2025.

Results View source PDF Explain this filing

MEDICO · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-0.5%Reaction day

₹53.24

prior close

₹53.14

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+0.6%-1.0% vs market

Pharmaceuticals peers, median of 157sector+0.1%-0.5% vs sector

On the reaction day the stock moved 1.0 pts less than Nifty Microcap 250 and 0.5 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-0.6

10m

-1.5

15m

-0.6

30m

-1.0

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-0.5+0.6-1.0+0.1-0.5

Next day

-1.2-0.2-1.0-0.7-0.5

-1.5-0.4-1.1-1.1-0.4

-4.2-0.7-3.5-0.9-3.4

-6.8-2.2-4.6-1.9-4.9

-7.2-2.8-4.4-3.1-4.1

-7.0-1.4-5.6-2.1-4.9

15d

+0.8-7.0+7.9-4.8+5.7

-7.0-6.1-0.9-5.0-2.0

-10.9-9.2-1.6-7.6-3.3

-11.1-6.8-4.2-9.5-1.6

UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 157Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Medico Remedies Limited has submitted its financial results for the quarter and half-year ended September 30, 2025 to NSE. The filing covers Q2 FY2026 and H1 FY2026 results, which typically include revenue, expenses, profit before tax, profit after tax, and EPS details. Specific numbers from the actual results document are not included in this notice — investors should refer to the detailed results PDF filed alongside this submission for the complete figures.

Likely market impact

This is a routine compliance filing confirming that the company has met its quarterly disclosure obligation. Actual stock or shareholder impact will depend on the underlying numbers in the detailed results, which are not available in this notice.